ECLIPSE: Assessment of Ultrasound-guided Inserted Peripheral Intravenous Catheter
Sponsor
Prodimed SAS (Industry)
Overall Status
Unknown status
CT.gov ID
NCT01602133
Collaborator
(none)
29
1
1
24
1.2
Study Details
Study Description
Brief Summary
Evaluate the safety and efficacy of an an ultrasound-guided inserted peripheral intravenous catheter during a period of seven days.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
29 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Official Title:
A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
Study Start Date
:
Jun 1, 2012
Anticipated Primary Completion Date
:
Jun 1, 2014
Anticipated Study Completion Date
:
Jun 1, 2014
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: one intervention arm
|
Procedure: peripheral venous puncture
Ultrasound imaging of the arm is performed. If a suitable vein is identified, a percutaneous puncture is performed under ultrasound guidance. Then, an intravenous catheter is inserted according Seldinger method.
|
Outcome Measures
Primary Outcome Measures
- length of use of the catheter measured in number of days [seven days]
Secondary Outcome Measures
- adverse event during the period of use of the catheter [seven days]
extravasation and/or catheter removal before the end of the treatment and/or local complications (bleeding, neurologic trouble, venous thrombosis..)
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Hospitalized patients with need of an intravenous therapy on peripheral line
-
Unsuccessful attempts at establishing a peripheral intravenous line by nurse
-
Age over 18 YO
-
Written informed consent obtained
Exclusion Criteria:
-
pregnant woman
-
local contra-indication for venous puncture
-
unconscious patient
-
need of intravenous therapy requiring central line
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Centre Hospitalier Sud Francilien | Corbeil-essonnes | France | 91 100 |
Sponsors and Collaborators
- Prodimed SAS
Investigators
- Principal Investigator: Pascal Meyer, MD, Centre Hospitalier Sud Francilien- Corbeil- France
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Prodimed SAS
ClinicalTrials.gov Identifier:
NCT01602133
Other Study ID Numbers:
- 2011-A01570-41
First Posted:
May 18, 2012
Last Update Posted:
Oct 25, 2012
Last Verified:
Oct 1, 2012